Michael Schieber

Years Active: 2018-2021
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Marinaccio, Praveen Suraneni, Hamza Celik, Andrew Volk, Qiang Jeremy Wen, Te Ling, Marinka Bulic, Terra Lasho, Richard P Koche, Christopher A Famulare, Noushin Farnoud, Brady Stein, Michael Schieber, Sandeep Gurbuxani, David E Root, Scott T Younger, Ronald Hoffman, Naseema Gangat, Panagiotis Ntziachristos, Navdeep S Chandel, Ross L Levine, Raajit K Rampal, Grant A Challen, Ayalew Tefferi, John D Crispino
LKB1/STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms. Cancer discovery 11 (6) (2021)
Michael Schieber, Christian Marinaccio, Lyndsey C Bolanos, Wendy D Haffey, Kenneth D Greis, Daniel T Starczynowski, John D Crispino
FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome. Blood cancer journal 10 (10) (2020)
Michael Schieber, John D Crispino, Brady Stein
Myelofibrosis in 2019: moving beyond JAK2 inhibition. Blood cancer journal 9 (9) (2019)
Michael Schieber, Leo I Gordon, Reem Karmali
Current overview and treatment of mantle cell lymphoma. F1000Research 7 (2018)

Michael Schieber.css-eqlu8i{font-size:small;padding-left:4px;}